Compliance

Practice happens where the patient’s body is, not where your clinician sits. Several states now say it in one sentence. It is the rule that decides which states your brand can actually open.

We opened the rules in seventeen states looking for the twelve-month good faith exam. It is not there. The law ties the exam to the order, and the triggers are events.

A board reads your chart to answer four questions: who examined this patient, what they found, what they ordered, and who carried it out. Washington wrote the checklist into a rule.

Both need a practitioner’s order for a federal reason: one is a prescription drug, the other a prescription device. Who examines and who injects is state law, and few states name either.

An outsourced exam is only as good as the license, the entity, the order and the record behind it. Ten questions, each tied to the rule that makes it matter.

The offer is a flat monthly fee, no site visits, and a business owned by someone without a license. Boards have a name for that arrangement, and it is not medical direction.

The RN injects. The RN does not evaluate. Every state that has written the rule down puts the exam with a physician, NP or PA, and puts it before the treatment.

Florida, Texas and California let a prescriber evaluate by video if the standard of care is met. Louisiana wants a physician on the premises. Mississippi does not count telemedicine hours at all.

Washington says yes, with a practitioner on the premises and no drug in the line. Texas says the person administering elective IV therapy is a PA, APRN or RN. California and Florida say no.

Louisiana lets an RN inject neurotoxin and bars the same RN from filler. Washington caps a physician at three PAs. Colorado lets unlicensed staff inject if you tell the patient.

Not for human consumption is doing enormous load-bearing work on peptide websites. The FDA has said in writing, repeatedly, that it does not control.

The supplement lane exists. Most peptides are not admitted to it, for structural reasons rather than enforcement priorities. Plus the branded path that is genuinely open.